{"id":414396,"date":"2021-01-13T16:04:10","date_gmt":"2021-01-13T21:04:10","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=414396"},"modified":"2021-01-13T16:04:10","modified_gmt":"2021-01-13T21:04:10","slug":"bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/","title":{"rendered":"Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement"},"content":{"rendered":"
\n

SAN DIEGO, Jan. 13, 2021 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that it has received a letter from the Nasdaq Listing Qualifications staff notifying the Company that it has regained compliance with Nasdaq’s minimum bid price requirement for continued listing on the Nasdaq Capital Market. The letter noted that as for the last 10 consecutive business days, from December 29, 2020 to January 12, 2021, the closing bid price of the Company’s common stock has been at $1.00 per share or greater, the Company has regained compliance with Listing Rule 5550(a)(2) and the matter is now closed.<\/p>\n

\n About Bionano Genomics<\/strong>
\n
Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano\u2019s Saphyr system is a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools, and genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs. Lineagen has been providing genetic testing services to families and their healthcare providers for over nine years and has performed over 65,000 tests for those with neurodevelopmental concerns. For more information, visit\u00a0www.bionanogenomics.com<\/u><\/a> or www.lineagen.com<\/a>.<\/p>\n

\n CONTACTS<\/strong>
\n
\n Company Contact:<\/strong>
\n
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionanogenomics.com<\/u><\/a><\/p>\n

\n Investor Relations Contact:<\/strong>
\n
Ashley R. Robinson
LifeSci Advisors, LLC
+1 (617) 430-7577
arr@lifesciadvisors.com<\/u><\/a><\/p>\n

\n Media Contact:<\/strong>
\n
Darren Opland, PhD
LifeSci Communications
+1 (617) 733-7668
darren@lifescicomms.com<\/u><\/a><\/p>\n

\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO, Jan. 13, 2021 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that it has received a letter from the Nasdaq Listing Qualifications staff notifying the Company that it has regained compliance with Nasdaq’s minimum bid price requirement for continued listing on the Nasdaq Capital Market. The letter noted that as for the last 10 consecutive business days, from December 29, 2020 to January 12, 2021, the closing bid price of the Company’s common stock has been at $1.00 per share or greater, the Company has regained compliance with Listing Rule 5550(a)(2) and the matter is now closed. About Bionano Genomics Bionano is a genome analysis company providing tools and services based on its Saphyr system to … <\/p>\n

Continue reading “Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-414396","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, Jan. 13, 2021 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that it has received a letter from the Nasdaq Listing Qualifications staff notifying the Company that it has regained compliance with Nasdaq’s minimum bid price requirement for continued listing on the Nasdaq Capital Market. The letter noted that as for the last 10 consecutive business days, from December 29, 2020 to January 12, 2021, the closing bid price of the Company’s common stock has been at $1.00 per share or greater, the Company has regained compliance with Listing Rule 5550(a)(2) and the matter is now closed. About Bionano Genomics Bionano is a genome analysis company providing tools and services based on its Saphyr system to … Continue reading "Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-13T21:04:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTU0NCMzOTE4MjM0IzUwMDA1MjUyMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement\",\"datePublished\":\"2021-01-13T21:04:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\\\/\"},\"wordCount\":311,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTU0NCMzOTE4MjM0IzUwMDA1MjUyMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\\\/\",\"name\":\"Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTU0NCMzOTE4MjM0IzUwMDA1MjUyMQ==\",\"datePublished\":\"2021-01-13T21:04:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTU0NCMzOTE4MjM0IzUwMDA1MjUyMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyNTU0NCMzOTE4MjM0IzUwMDA1MjUyMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/","og_locale":"en_US","og_type":"article","og_title":"Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement - Market Newsdesk","og_description":"SAN DIEGO, Jan. 13, 2021 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that it has received a letter from the Nasdaq Listing Qualifications staff notifying the Company that it has regained compliance with Nasdaq’s minimum bid price requirement for continued listing on the Nasdaq Capital Market. The letter noted that as for the last 10 consecutive business days, from December 29, 2020 to January 12, 2021, the closing bid price of the Company’s common stock has been at $1.00 per share or greater, the Company has regained compliance with Listing Rule 5550(a)(2) and the matter is now closed. About Bionano Genomics Bionano is a genome analysis company providing tools and services based on its Saphyr system to … Continue reading \"Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-13T21:04:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTU0NCMzOTE4MjM0IzUwMDA1MjUyMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement","datePublished":"2021-01-13T21:04:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/"},"wordCount":311,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTU0NCMzOTE4MjM0IzUwMDA1MjUyMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/","name":"Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTU0NCMzOTE4MjM0IzUwMDA1MjUyMQ==","datePublished":"2021-01-13T21:04:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTU0NCMzOTE4MjM0IzUwMDA1MjUyMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyNTU0NCMzOTE4MjM0IzUwMDA1MjUyMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-regains-compliance-with-nasdaq-minimum-bid-price-listing-requirement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/414396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=414396"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/414396\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=414396"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=414396"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=414396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}